RVX-28

New Data on RVX-28’s Function in Reducing CVD Risk Was Presented at ESC Congress This Year

New Data on RVX-28’s Function in Reducing CVD Risk Was Presented at ESC Congress This Year

September 1, 2015
 |  No Comments
 |  Research Hotspot

Dr. Norman Wong, a scientific chief officer from Resverlogix Corp. made a presentation at the ESC Congress 2015 on RVX-28 inhibitor, functioning on lowering the CVD risk, in which new […]